-
Crowther and associates reported the results of a prospective, randomized, controlled study of the use of 2 intensities of warfarin anticoagulation for prevention of thrombosis in patients with the antiphospholipid antibody syndrome who had previous thrombosis.
-
The management of blood pressure in the acute phase of ischemic stroke is not well understood. In fact, it has been advocated by some that the pharmacologic elevation of blood pressure may augment perfusion to the ischemic penumbra and improve stroke outcome.
-
Neuropathic pain, specifically allodynia following peripheral nerve injury, is a poorly understood phenomenon that challenges clinicians and patients. Tsuda and associates report on animal data that may reveal insights into the underlying mechanism of tactile allodynia.
-
Amyotrophic lateral sclerosis (ALS) is a clinical diagnosis made with a high degree of accuracy (> 90%) by physicians familiar with the disease. No test is diagnostic for ALS.
-
Practice Parameter for Guillain Barré Syndrome; Symposium on Dementia
-
-
The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.
-
Update your knowledge on current issues in reproductive health at the annual Contraceptive Technology conference. The Washington, DC, session is scheduled for Feb. 29-March 3, with the San Francisco session set for March 24-27.
-
Will adding male programs to existing family planning services subtract from existing care?
-
Review the number of services offered at your family planning agency, then check off the number that address the reproductive health needs of men. If your agency is like most of the facilities participating in a recently published survey, you may be serving some male patients, but doing very little to recruit more.
